• OPEN AN ACCOUNT
Indian Indices
Sensex
78,954.76 373.76
( 0.48%)
Global Indices
Nasdaq
53,904.84 -465.28
(-0.86%)
Dow Jones
7,729.00 -15.55
(-0.20%)
Hang Seng
65,663.80 -636.64
(-0.96%)
Nikkei 225
10,873.25 -15.05
(-0.14%)
Forex
USD-INR
95.23 -0.06
(-0.07%)
EUR-INR
109.68 -0.11
(-0.10%)
GBP-INR
127.98 -0.19
(-0.15%)
JPY-INR
0.60 0.00
(-0.60%)

EQUITY - MARKET SCREENER

Alembic Pharmaceuticals Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
533573
INE901L01018
285.6722314
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
APLLTD
20.79
16405.16
EPS(TTM)
Face Value()
Div & Yield %
40.14
2
1.44
 

Silgo Retail consolidated net profit rises 9.20% in the March 2026 quarter
May 30,2026
Net profit of Silgo Retail rose 9.20% to Rs 1.90 crore in the quarter ended March 2026 as against Rs 1.74 crore during the previous quarter ended March 2025. Sales declined 19.06% to Rs 13.38 crore in the quarter ended March 2026 as against Rs 16.53 crore during the previous quarter ended March 2025.

For the full year,net profit rose 27.23% to Rs 5.70 crore in the year ended March 2026 as against Rs 4.48 crore during the previous year ended March 2025. Sales rose 6.00% to Rs 47.03 crore in the year ended March 2026 as against Rs 44.37 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales13.3816.53 -19 47.0344.37 6
OPM %25.4115.49 -18.6314.09 -
PBDT2.762.43 14 8.026.10 31
PBT2.762.42 14 7.996.07 32
NP1.901.74 9 5.704.48 27